Opaleye Management Inc. - AVENUE THERAPEUTICS INC ownership

AVENUE THERAPEUTICS INC's ticker is ATXI and the CUSIP is 05360L205. A total of 37 filers reported holding AVENUE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of AVENUE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$10,664,000
-4.3%
984,692
-4.9%
2.09%
-7.3%
Q2 2020$11,147,000
+20.5%
1,035,0000.0%2.25%
-8.2%
Q1 2020$9,253,000
-6.9%
1,035,0000.0%2.45%
+25.7%
Q4 2019$9,936,000
+75.0%
1,035,000
+8.7%
1.95%
-5.0%
Q3 2019$5,677,000
-3.1%
952,600
+2.4%
2.05%
+14.9%
Q2 2019$5,859,000
+54.2%
930,000
+16.2%
1.79%
+69.8%
Q1 2019$3,800,000
+41.9%
800,000
+61.3%
1.05%
+5.3%
Q4 2018$2,678,000496,0001.00%
Other shareholders
AVENUE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
EMFO, LLC 16,000$4,0000.00%
B. Riley Wealth Advisors, Inc. 58,330$16,0000.00%
BNP PARIBAS FINANCIAL MARKETS 8$2,0000.00%
WELLS FARGO & COMPANY/MN 68,067$18,0000.00%
NORTHERN TRUST CORP 13,767$4,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 84,033$22,0000.00%
MILLENNIUM MANAGEMENT LLC 11,247$3,0000.00%
CITIGROUP INC 500$00.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 25,707$7,0000.00%
View complete list of AVENUE THERAPEUTICS INC shareholders